Compel Magnetic COOH Microspheres
To Order Contact us: stephen@expresspharmapulse.com
Absolute Mag PEG-COOH Magnetic Dextran Nanoparticles, 20 nm |
|||
| WHM-G062 | Creative Diagnostics | 5 mL | EUR 572 |
Absolute Mag PEG-COOH Magnetic Dextran Nanoparticles, 50 nm |
|||
| WHM-G070 | Creative Diagnostics | 5 mL | EUR 502 |
Absolute Mag PEG-COOH Magnetic Dextran Nanoparticles, 100 nm |
|||
| WHM-G080 | Creative Diagnostics | 5 mL | EUR 502 |
Absolute Mag PEG-COOH Magnetic Polystyrene Particles, 2 µm |
|||
| WHM-G138 | Creative Diagnostics | 10 mL | EUR 844 |
Absolute Mag PEG-COOH Magnetic Polystyrene Particles, 3 µm |
|||
| WHM-G139 | Creative Diagnostics | 10 mL | EUR 844 |
Absolute Mag PEG-COOH Magnetic Polystyrene Particles, 4 µm |
|||
| WHM-G140 | Creative Diagnostics | 10 mL | EUR 844 |
Absolute Mag PEG-COOH Magnetic Polystyrene Particles, 5 µm |
|||
| WHM-G141 | Creative Diagnostics | 10 mL | EUR 844 |
Absolute Mag PEG-COOH Magnetic Polystyrene Particles, 6 µm |
|||
| WHM-G142 | Creative Diagnostics | 10 mL | EUR 844 |
Absolute Mag PEG-COOH Magnetic Polystyrene Particles, 7 µm |
|||
| WHM-G143 | Creative Diagnostics | 10 mL | EUR 844 |
Absolute Mag PEG-COOH Magnetic Polystyrene Particles, 8 µm |
|||
| WHM-G144 | Creative Diagnostics | 10 mL | EUR 844 |
Absolute Mag PEG-COOH Magnetic Polystyrene Particles, 10 µm |
|||
| WHM-G145 | Creative Diagnostics | 10 mL | EUR 844 |
Absolute Mag PEG-COOH Magnetic Polystyrene Particles, 12 µm |
|||
| WHM-G146 | Creative Diagnostics | 10 mL | EUR 844 |
Absolute Mag PEG-COOH Silica Magnetic Particles, 250 nm |
|||
| WHM-MC01 | Creative Diagnostics | 5 mL | EUR 689 |
COOH-PEG3-COOH |
|||
| 20-abx085430 | Abbexa |
|
|
COOH-PEG-COOH |
|||
| abx085041-03kDa1g | Abbexa | 0.3 kDa; 1 g | EUR 356 |
COOH-PEG-COOH |
|||
| abx085041-08kDa1g | Abbexa | 0.8 kDa; 1 g | EUR 384 |
COOH-PEG-COOH |
|||
| abx085041-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 384 |
COOH-PEG-COOH |
|||
| abx085041-6kDa1g | Abbexa | 6 kDa; 1 g | EUR 384 |
Absolute Mag PEG-COOH Magnetic Nanoparticles, Dextran Coated, 130 nm |
|||
| WHM-G026 | Creative Diagnostics | 10 mL | EUR 711 |
Absolute Mag PEG-COOH Magnetic Nanoparticles, Dextran Coated, 250 nm |
|||
| WHM-G041 | Creative Diagnostics | 10 mL | EUR 677 |
Absolute Mag PEG-COOH Magnetic Nanoparticles, Dextran Coated, 500 nm |
|||
| WHM-G052 | Creative Diagnostics | 10 mL | EUR 711 |
Absolute Mag PEG-COOH Magnetic Nanoparticles, Hydroxyethyl Starch, 80 nm |
|||
| WHM-G112 | Creative Diagnostics | 5 mL | EUR 572 |
Absolute Mag PEG-COOH Magnetic Nanoparticles, Dextran Coated, 80 nm |
|||
| WHM-G113 | Creative Diagnostics | 5 mL | EUR 572 |
Absolute Mag PEG-COOH Magnetic Nanoparticles, Hydroxyethyl Starch, 100 nm |
|||
| WHM-G126 | Creative Diagnostics | 5 mL | EUR 551 |
Absolute Mag PEG-COOH Magnetic Nanoparticles, Dextran Coated, 100 nm |
|||
| WHM-G127 | Creative Diagnostics | 5 mL | EUR 551 |
Absolute Mag Gold Coated Magnetic Particles, COOH-PEG 3000Da, 50nm |
|||
| WHM-GC02 | Creative Diagnostics | 1mL | EUR 876 |
Absolute Mag Gold Coated Magnetic Particles, COOH-PEG 5000Da, 50nm |
|||
| WHM-GC03 | Creative Diagnostics | 1mL | EUR 876 |
Silica Microspheres, Amine, 0.5um |
|||
| SA03N-1 | Bangs Laboratories | 1 g | EUR 518.29 |
|
Description: Silica Microspheres, Amine, 0.5um are bead platform with improved binding kinetics over planar ssurfaces, robust statistics, flexible silanization chemistries, unique refractive index and density, low autofluorescence, low nonspecific binding of many biomolecules |
|||
Silica Microspheres, Amine, 1.0um |
|||
| SA04N-1 | Bangs Laboratories | 1 g | EUR 518.29 |
|
Description: Silica Microspheres, Amine, 1.0um are bead platform with improved binding kinetics over planar ssurfaces, robust statistics, flexible silanization chemistries, unique refractive index and density, low autofluorescence, low nonspecific binding of many biomolecules |
|||
Silica Microspheres, Amine, 5.0um |
|||
| SA05N-1 | Bangs Laboratories | 1 g | EUR 841.28 |
|
Description: Silica Microspheres, Amine, 5.0um are bead platform with improved binding kinetics over planar ssurfaces, robust statistics, flexible silanization chemistries, unique refractive index and density, low autofluorescence, low nonspecific binding of many biomolecules |
|||
Silica Microspheres, Carboxyl, 0.5um |
|||
| SC03N-1 | Bangs Laboratories | 1 g | EUR 518.29 |
|
Description: Silica Microspheres, Carboxyl, 0.5um are bead platform with improved binding kinetics over planar ssurfaces, robust statistics, flexible silanization chemistries, unique refractive index and density, low autofluorescence, low nonspecific binding of many biomolecules |
|||
Silica Microspheres, Carboxyl, 1.0um |
|||
| SC04N-1 | Bangs Laboratories | 1 g | EUR 518.29 |
|
Description: Silica Microspheres, Carboxyl, 1.0um are bead platform with improved binding kinetics over planar ssurfaces, robust statistics, flexible silanization chemistries, unique refractive index and density, low autofluorescence, low nonspecific binding of many biomolecules |
|||
Silica Microspheres, Carboxyl, 5.0um |
|||
| SC05N-1 | Bangs Laboratories | 1 g | EUR 841.28 |
|
Description: Silica Microspheres, Carboxyl, 5.0um are bead platform with improved binding kinetics over planar ssurfaces, robust statistics, flexible silanization chemistries, unique refractive index and density, low autofluorescence, low nonspecific binding of many biomolecules |
|||
Silica Microspheres - Dry, 0.3um |
|||
| SS02N-1.5 | Bangs Laboratories | 1,5 g | EUR 460.65 |
|
Description: Silica Microspheres - Dry, 0.3um with natural hydroxyl or silanol surface groups. Suitable for use for proteins with low binding capacity. |
|||
Silica Microspheres - Dry, 0.5um |
|||
| SS03N-1.5 | Bangs Laboratories | 1,5 g | EUR 460.65 |
|
Description: Silica Microspheres - Dry, 0.5um with natural hydroxyl or silanol surface groups. Suitable for use for proteins with low binding capacity. |
|||
Silica Microspheres - Dry, 1.5um |
|||
| SS04N-1.5 | Bangs Laboratories | 1,5 g | EUR 645.53 |
|
Description: Silica Microspheres - Dry, 1.5um with natural hydroxyl or silanol surface groups. Suitable for use for proteins with low binding capacity. |
|||
Silica Microspheres - Dry, 4.0um |
|||
| SS05N-1.5 | Bangs Laboratories | 1,5 g | EUR 755.36 |
|
Description: Silica Microspheres - Dry, 4.0um with natural hydroxyl or silanol surface groups. Suitable for use for proteins with low binding capacity. |
|||
Silica Microspheres - Dry, 5.0um |
|||
| SS06N-1.5 | Bangs Laboratories | 1,5 g | EUR 755.36 |
|
Description: Silica Microspheres - Dry, 5.0um with natural hydroxyl or silanol surface groups. Suitable for use for proteins with low binding capacity. |
|||
COOH-PEG-COOH,10K |
|||
| 33-HO017017-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,1K |
|||
| 33-HO017017-1K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,20K |
|||
| 33-HO017017-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,2K |
|||
| 33-HO017017-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,3.4K |
|||
| 33-HO017017-3.4K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,300 |
|||
| 33-HO017017-300 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,400 |
|||
| 33-HO017017-400 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,4K |
|||
| 33-HO017017-4K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,500 |
|||
| 33-HO017017-500 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,5K |
|||
| 33-HO017017-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,600 |
|||
| 33-HO017017-600 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,6K |
|||
| 33-HO017017-6K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,7.5K |
|||
| 33-HO017017-7.5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
COOH-PEG-COOH,800 |
|||
| 33-HO017017-800 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Boc-COOH-PEG-COOH |
|||
| abx085267-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 801 |
Boc-COOH-PEG-COOH |
|||
| abx085267-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 801 |
Boc-COOH-PEG-COOH |
|||
| abx085267-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 801 |
Boc-COOH-PEG-COOH |
|||
| abx085267-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 801 |
Boc-COOH-PEG-COOH,10K |
|||
| 33-HE073017-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Boc-COOH-PEG-COOH,20K |
|||
| 33-HE073017-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Boc-COOH-PEG-COOH,2K |
|||
| 33-HE073017-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Boc-COOH-PEG-COOH,3.4K |
|||
| 33-HE073017-3.4K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Boc-COOH-PEG-COOH,5K |
|||
| 33-HE073017-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.10um |
|||
| FCEU001-1 | Bangs Laboratories | 1 ml | EUR 219.23 |
|
Description: FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.10um are exceptional staible, in addition to well-functionalized carboxylated surfaces for the covalent attachment of ligand. |
|||
FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.10um |
|||
| FCEU001-10 | Bangs Laboratories | 10 ml | EUR 806.48 |
|
Description: FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.10um are exceptional staible, in addition to well-functionalized carboxylated surfaces for the covalent attachment of ligand. |
|||
FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.10um |
|||
| FCEU001-5 | Bangs Laboratories | 5 ml | EUR 585.71 |
|
Description: FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.10um are exceptional staible, in addition to well-functionalized carboxylated surfaces for the covalent attachment of ligand. |
|||
FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.20um |
|||
| FCEU002-1 | Bangs Laboratories | 1 ml | EUR 219.23 |
|
Description: FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.20um are exceptional staible, in addition to well-functionalized carboxylated surfaces for the covalent attachment of ligand. |
|||
FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.20um |
|||
| FCEU002-10 | Bangs Laboratories | 10 ml | EUR 806.48 |
|
Description: FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.20um are exceptional staible, in addition to well-functionalized carboxylated surfaces for the covalent attachment of ligand. |
|||
FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.20um |
|||
| FCEU002-5 | Bangs Laboratories | 5 ml | EUR 585.71 |
|
Description: FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.20um are exceptional staible, in addition to well-functionalized carboxylated surfaces for the covalent attachment of ligand. |
|||
FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.30um |
|||
| FCEU003-1 | Bangs Laboratories | 1 ml | EUR 219.23 |
|
Description: FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.30um are exceptional staible, in addition to well-functionalized carboxylated surfaces for the covalent attachment of ligand. |
|||
FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.30um |
|||
| FCEU003-10 | Bangs Laboratories | 10 ml | EUR 806.48 |
|
Description: FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.30um are exceptional staible, in addition to well-functionalized carboxylated surfaces for the covalent attachment of ligand. |
|||
FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.30um |
|||
| FCEU003-5 | Bangs Laboratories | 5 ml | EUR 585.71 |
|
Description: FluoresbriteEuropium (Eu) Carboxylate Microspheres 0.30um are exceptional staible, in addition to well-functionalized carboxylated surfaces for the covalent attachment of ligand. |
|||
ProMag 3 Series Streptavidin Microspheres |
|||
| PMS3N-1 | Bangs Laboratories | 1 ml | EUR 221.4 |
|
Description: ProMag 3 Series Streptavidin Microspheressuitable for use in assay developmen. This item is supplied as suspension in water. |
|||
ProMag 3 Series Streptavidin Microspheres |
|||
| PMS3N-10 | Bangs Laboratories | 10 ml | EUR 929.36 |
|
Description: ProMag 3 Series Streptavidin Microspheressuitable for use in assay developmen. This item is supplied as suspension in water. |
|||
ProMag 3 Series Streptavidin Microspheres |
|||
| PMS3N-2 | Bangs Laboratories | 2 ml | EUR 330.15 |
|
Description: ProMag 3 Series Streptavidin Microspheressuitable for use in assay developmen. This item is supplied as suspension in water. |
|||
ProMag 3 Series Streptavidin Microspheres |
|||
| PMS3N-5 | Bangs Laboratories | 5 ml | EUR 569.4 |
|
Description: ProMag 3 Series Streptavidin Microspheressuitable for use in assay developmen. This item is supplied as suspension in water. |
|||
Absolute Mag PEG-COOH Magnetic Nanoparticles, Cross-linked Dextran Coated, 300 nm |
|||
| WHM-G091 | Creative Diagnostics | 10 mL | EUR 921 |
Absolute Mag PEG-COOH Magnetic Nanoparticles, Cross-linked Dextran Coated, 500 nm |
|||
| WHM-G095 | Creative Diagnostics | 10 mL | EUR 956 |
CY5.5-COOH |
|||
| abx187851-1g | Abbexa | 1 g | EUR 1831 |
mPEG-COOH |
|||
| abx085349-035kDa1g | Abbexa | 0.35 kDa; 1 g | EUR 262 |
mPEG-COOH |
|||
| abx085349-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 298 |
mPEG-COOH |
|||
| abx085349-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 322 |
mPEG-COOH |
|||
| abx085349-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 327 |
mPEG-COOH |
|||
| abx085349-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 322 |
N33-TEG-COOH |
|||
| HY-108370 | MedChemExpress | 100mg | EUR 108 |
Thalidomide-O-COOH |
|||
| HY-103597 | MedChemExpress | 100mg | EUR 509 |
NH2-KLGADTDGEQDQHMTYGGQ-COOH |
|||
| HY-P0182 | MedChemExpress | 5mg | EUR 505 |
Flunixin(COOH) [HRP] |
|||
| DAG1196 | Creative Diagnostics | 0.5ml | EUR 897 |
Flunixin COOH [BSA] |
|||
| DAGA-269B | Creative Diagnostics | 1 mg | EUR 1001 |
Flunixin COOH [KLH] |
|||
| DAGA-269K | Creative Diagnostics | 1 mg | EUR 975 |
DSPE-PEG-COOH |
|||
| 33-LP096017-1K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-COOH?10K |
|||
| 33-MF001017-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-COOH?1K |
|||
| 33-MF001017-1K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-COOH?2K |
|||
| 33-MF001017-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-COOH?350 |
|||
| 33-MF001017-350 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-COOH?500 |
|||
| 33-MF001017-500 | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
mPEG-COOH?5K |
|||
| 33-MF001017-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
NH2-PEG2-COOH |
|||
| 20-abx186615 | Abbexa |
|
|
NH2-PEG3-COOH |
|||
| 20-abx186616 | Abbexa |
|
|
Biotin-PEG-COOH |
|||
| abx085074-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 801 |
Biotin-PEG-COOH |
|||
| abx085074-34kDa1g | Abbexa | 3.4 kDa; 1 g | EUR 996 |
Biotin-PEG-COOH |
|||
| abx085074-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 996 |
NH2-PEG-COOH |
|||
| abx085124-03kDa1g | Abbexa | 0.3 kDa; 1 g | EUR 565 |
NH2-PEG-COOH |
|||
| abx085124-05kDa1g | Abbexa | 0.5 kDa; 1 g | EUR 565 |
NH2-PEG-COOH |
|||
| abx085124-08kDa1g | Abbexa | 0.8 kDa; 1 g | EUR 565 |
NH2-PEG-COOH |
|||
| abx085124-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 565 |
NH2-PEG-COOH |
|||
| abx085124-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 565 |
ACA-PEG-COOH |
|||
| abx085144-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 718 |
ACA-PEG-COOH |
|||
| abx085144-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 718 |
ACA-PEG-COOH |
|||
| abx085144-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 718 |
ACA-PEG-COOH |
|||
| abx085144-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 718 |
DSPE-PEG-COOH |
|||
| abx085147-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 982 |
DSPE-PEG-COOH |
|||
| abx085147-2kDa2g | Abbexa | 2 kDa; 2 g | EUR 1163 |
DSPE-PEG-COOH |
|||
| abx085147-2kDa5g | Abbexa | 2 kDa; 5 g | EUR 1831 |
DSPE-PEG-COOH |
|||
| abx085147-34kDa1g | Abbexa | 3.4 kDa; 1 g | EUR 982 |
DSPE-PEG-COOH |
|||
| abx085147-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 982 |
FA-PEG-COOH |
|||
| abx085158-10kDa100mg | Abbexa | 10 kDa; 100 mg | EUR 592 |
FA-PEG-COOH |
|||
| abx085158-1kDa100mg | Abbexa | 1 kDa; 100 mg | EUR 578 |
FA-PEG-COOH |
|||
| abx085158-20kDa100mg | Abbexa | 20 kDa; 100 mg | EUR 592 |
FA-PEG-COOH |
|||
| abx085158-34kDa100mg | Abbexa | 3.4 kDa; 100 mg | EUR 620 |
FA-PEG-COOH |
|||
| abx085158-4kDa100mg | Abbexa | 4 kDa; 100 mg | EUR 592 |
Silane-PEG-COOH |
|||
| abx085160-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 801 |
Silane-PEG-COOH |
|||
| abx085160-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 801 |
Silane-PEG-COOH |
|||
| abx085160-5kDa5g | Abbexa | 5 kDa; 5 g | EUR 2054 |
DLPE-PEG-COOH |
|||
| abx085183-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 773 |
DLPE-PEG-COOH |
|||
| abx085183-34kDa1g | Abbexa | 3.4 kDa; 1 g | EUR 773 |
DLPE-PEG-COOH |
|||
| abx085183-34kDa5g | Abbexa | 3.4 kDa; 5 g | EUR 1970 |
DLPE-PEG-COOH |
|||
| abx085183-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 773 |
Cholesterol-PEG-COOH |
|||
| abx085190-2kDa100mg | Abbexa | 2 kDa; 100 mg | EUR 481 |
Cholesterol-PEG-COOH |
|||
| abx085190-34kDa100mg | Abbexa | 3.4 kDa; 100 mg | EUR 481 |
Cholesterol-PEG-COOH |
|||
| abx085190-34kDa500mg | Abbexa | 3.4 kDa; 500 mg | EUR 1107 |
Cholesterol-PEG-COOH |
|||
| abx085190-5kDa100mg | Abbexa | 5 kDa; 100 mg | EUR 481 |
DMPE-PEG-COOH |
|||
| abx085197-34kDa1g | Abbexa | 3.4 kDa; 1 g | EUR 1274 |
DMPE-PEG-COOH |
|||
| abx085197-34kDa500mg | Abbexa | 3.4 kDa; 500 mg | EUR 801 |
DMPE-PEG-COOH |
|||
| abx085197-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 1274 |
DMPE-PEG-COOH |
|||
| abx085197-5kDa500mg | Abbexa | 5 kDa; 500 mg | EUR 801 |
DPPE-PEG-COOH |
|||
| abx085200-2kDa500mg | Abbexa | 2 kDa; 500 mg | EUR 801 |
DPPE-PEG-COOH |
|||
| abx085200-34kDa1g | Abbexa | 3.4 kDa; 1 g | EUR 1274 |
DPPE-PEG-COOH |
|||
| abx085200-34kDa500mg | Abbexa | 3.4 kDa; 500 mg | EUR 801 |
DPPE-PEG-COOH |
|||
| abx085200-5kDa500mg | Abbexa | 5 kDa; 500 mg | EUR 801 |
NHS-PEG-COOH |
|||
| abx085212-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 592 |
NHS-PEG-COOH |
|||
| abx085212-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 578 |